Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Pets At Home CEO raises stake

(Sharecast News) - Pets At Home revealed on Friday that chief executive Lyssa McGowan had acquired 42,294 ordinary shares in the FTSE 250-listed animal products retailer. McGowan, who took over as CEO in June 2022, purchased the shares on Thursday at an average price of 236.44p each, for a total value of £99,998.67.

As of 1615 GMT, Pets At Home shares were down 0.34% at 232.0p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Pets At Home Group (PETS) Director name: McGowan,Lyssa Amount purchased: 42,294 @ 236.44p Value: £99,998.67

Smiths News (SNWS) Director name: Rabey,Deborah Amount purchased: 20,663 @ 62.60p Value: £12,935.04

Accsys Technologies (AXS) Director name: Eperjesi,Louis Amount purchased: 21,000 @ 47.50p Value: £9,975.00

Topps Tiles (TPT) Director name: Payne,Martin Amount purchased: 25,000 @ 38.99p Value: £9,747.50

Top Director Sells

Coca-cola Hbc Ag (cdi) (CCH) Director name: Leventis,Anastasios I Amount sold: 8,000 @ 2,827.70p Value: £226,216.14

Share this article

Related Sharecast Articles

Director dealings: Essentra CEO raises stake
(Sharecast News) - Essentra revealed on Wednesday that chief execuitve Scott Fawcett had acquired 17,483 ordinary shares in the FTSE 250-listed hardware manufacturer.
Director dealings: AB Dynamics CEO snaps up shares
(Sharecast News) - AB Dynamics revealed on Tuesday that chief executive Sarah Matthews-DeMers had acquired 2,000 ordinar shares in the AIM-listed automotive testing and development solution supplier.
Director dealings: Bioventix chairman raises stake
(Sharecast News) - Bioventix revealed on Monday that chairman Ian Nicholson had acquired 1,000 ordinary shares in the AIM-listed biotechnology firm.
Director dealings: Bioventix chairman raises stake
(Sharecast News) - Bioventix revealed on Monday that chairman Ian Nicholson had acquired 1,000 ordinary shares in the AIM-listed biotechnology firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.